These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11217095)

  • 1. Biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice.
    Kofuji K; Ito T; Murata Y; Kawashima S
    Biol Pharm Bull; 2001 Feb; 24(2):205-8. PubMed ID: 11217095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chondroitin sulfate on the biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice.
    Kofuji K; Ito T; Murata Y; Kawashima S
    Biol Pharm Bull; 2002 Feb; 25(2):268-71. PubMed ID: 11853181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation.
    Kofuji K; Akamine H; Qian CJ; Watanabe K; Togan Y; Nishimura M; Sugiyama I; Murata Y; Kawashima S
    Int J Pharm; 2004 Mar; 272(1-2):65-78. PubMed ID: 15019070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controlled release of a drug from biodegradable chitosan gel beads.
    Kofuji K; Ito T; Murata Y; Kawashima S
    Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):579-81. PubMed ID: 10783085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention and release behavior of insulin in chitosan gel beads.
    Kofuji K; Akamine H; Oshirabe H; Maeda Y; Murata Y; Kawashima S
    J Biomater Sci Polym Ed; 2003; 14(11):1243-53. PubMed ID: 14768911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions.
    Kofuji K; Murata Y; Kawashima S
    Int J Pharm; 2005 Oct; 303(1-2):95-103. PubMed ID: 16139972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of alginate gel beads containing chitosan nicotinic acid salt and the functions.
    Murata Y; Toniwa S; Miyamoto E; Kawashima S
    Eur J Pharm Biopharm; 1999 Jul; 48(1):49-52. PubMed ID: 10477328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of alginate-chitosan gastric floating beads loading with oxymatrine solid dispersion.
    Liu Y; Chen L; Zhou C; Yang J; Hou Y; Wang W
    Drug Dev Ind Pharm; 2016; 42(3):456-63. PubMed ID: 26422447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and drug retention of biodegradable chitosan gel beads.
    Kofuji K; Shibata K; Murata Y; Miyamoto E; Kawashima S
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1494-6. PubMed ID: 10553646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system.
    Xu Y; Zhan C; Fan L; Wang L; Zheng H
    Int J Pharm; 2007 May; 336(2):329-37. PubMed ID: 17223290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior of alginate gel beads containing chitosan salt prepared with water-soluble vitamins.
    Murata Y; Kontani Y; Ohmae H; Kawashima S
    Eur J Pharm Biopharm; 2002 Mar; 53(2):249-51. PubMed ID: 11880010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
    Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
    Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of an alginate gel bead containing a chitosan-drug salt.
    Murata Y; Hirai D; Kofuji K; Miyamoto E; Kawashima S
    Biol Pharm Bull; 2004 Mar; 27(3):440-2. PubMed ID: 14993820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery.
    Wang FQ; Li P; Zhang JP; Wang AQ; Wei Q
    Drug Dev Ind Pharm; 2010 Jul; 36(7):867-77. PubMed ID: 20345282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release behavior of beads and microgranules of chitosan.
    Gupta KC; Ravi Kumar MN
    Biomaterials; 2000 Jun; 21(11):1115-9. PubMed ID: 10817263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan matrix for oral sustained delivery of ampicillin.
    Chandy T; Sharma CP
    Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular weight and degree of deacetylation effects on lipase-loaded chitosan bead characteristics.
    Alsarra IA; Betigeri SS; Zhang H; Evans BA; Neau SH
    Biomaterials; 2002 Sep; 23(17):3637-44. PubMed ID: 12109689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
    Lin WC; Yu DG; Yang MC
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable chitosan matrix for the controlled release of steroids.
    Chandy T; Sharma CP
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):745-60. PubMed ID: 1810408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.